Skip to content

Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation

Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00860106
Acronym
VAPRED
Enrollment
222
Registered
2009-03-11
Start date
2005-03-31
Completion date
2011-05-31
Last updated
2011-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Previous Proximal VTE, Previous Vka Treatment

Keywords

VTE, VKA treatment, VKA treatment cessation

Brief summary

The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation. The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.

Detailed description

DDimer levels are centralized in University Hospital of Grenoble at the end of the study

Interventions

OTHERED, DDimers and phone follow up

ED score, DDimers level and phone questionnary

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* \> 18 and \<80 years old * First or second treated proximal VTE event (+/- Pulmonary embolism) * Signed informed consent

Exclusion criteria

* Active cancer or currently treated * Previous VTE\>2 * Long term anticoagulant treatment for VTE diseases * Long term anticoagulant treatment for other diseases * Pregnancy, parturient or breast feeding * Person deprived of freedom by judicial or administrative decision * Consent unsigned

Design outcomes

Primary

MeasureTime frame
VTE event recurrence0-2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026